Weizmann Institute Scientists Find that Targeting a Chronic Pain Gateway Could Bring Relief

A study led by Prof. Mike Fainzilber identifies a potential new approach to treating chronic pain: targeting an importin molecule that moves pain messages into nerve cell nuclei. The team can now “conduct screens for new and better drug molecules that can precisely target this chain of events in the sensory neurons.”